Plus Therapeutics Regains Nasdaq Compliance; Reports $3M Stockholders' Equity and $35M+ MVLS

PLUS THERAPEUTICS, INC.

Reported stockholders' equity of $3M as of June 30, 2025, satisfying Nasdaq's minimum $2.5M Equity Rule.
Sold over $2M in common stock via a $50M equity line of credit with Lincoln Park Capital Fund since June 30.
As of August 13, 2025, market value of listed securities exceeded $35M for 20 consecutive business days, meeting the alternative MVLS requirement.
Company awaits formal Nasdaq confirmation that it has evidenced compliance with either or both listing standards.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-180814
form_type: 8-K
ticker: PSTV
cik: 0001095981
company_name: PLUS THERAPEUTICS, INC.
filed_at: 2025-08-14T23:59:59+00:00
discovered_at: 2026-05-14T18:02:43.327867+00:00
generated_at: 2026-05-17T12:47:15.261042+00:00
sec_items: ["8.01", "9.01"]
event_type: other
sentiment: positive
materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-180814
json_url: https://secwatch.observer/filing/0001193125-25-180814.json
markdown_url: https://secwatch.observer/filing/0001193125-25-180814.md
text_url: https://secwatch.observer/filing/0001193125-25-180814.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312525180814/0001193125-25-180814-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312525180814/d824499d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-25-180814

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.